Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03135730 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Rapid-onset Obesity With Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Sponsor changed: Debra Weese-Mayer to Ilya Khaytinv13
  2. Notable Primary completion date: Dec 31, 2024 to Dec 31, 2034
    • Study completion date: Dec 31, 2025 to Dec 31, 2039
    • Site contact updated
    v12
  3. Notable Enrollment target: 500 to 1000v11
  4. Minor Re-verified, no change to tracked fieldsv10
  5. Notable Enrollment target: 250 to 500v9
Show 7 earlier versionsHide 7 earlier versions
  1. Notable Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    • Secondary endpoints: details revised at 1 of 2 entries
    v8
  2. Notable Primary completion date: Dec 31, 2021 to Dec 31, 2023
    • Study completion date: Dec 31, 2022 to Dec 31, 2024
    v7
  3. Minor 2 versions Re-verified since Jul 23, 2019, no change to tracked fieldsv5-v6
  4. Minor Site contact updatedv4
  5. Minor Re-verified, no change to tracked fieldsv3
  6. Minor Enrollment target: 200 to 250
    • Site contact updated
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,874 trials monitored
See 152 trials at risk
The Center for Autonomic Medicine in Pediatrics (CAMP) has collaborated with doctors from around the world to build the first International ROHHAD (Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation and Autonomic Dysregulation) REDCap (Research Electronic Data Capture) Registry. This registry is an international collaboration with ROHHAD patients and their physicians recruited from around the world. The purpose of this IRB-approved research study is to gain a better understanding of the various health problems ROHHAD patients face with advancing age, and how these relate to each patient's specific medical course. With a better understanding of specific ROHHAD and associated clinical manifestations, we will be able to better anticipate healthcare needs and to provide more accurate guidelines to healthcare providers world-wide in caring for patients with ROHHAD. The study aims to obtain detailed phenotypic information (information about health and well-being) on patients with ROHHAD. Participation would require filling out a confidential survey that asks questions regarding health and past medical history. Involvement in the project is completely voluntary and there is no compensation for taking part. However, this project will help us learn more about this devastating disease, with the goal of advancing treatment.
Trial Details
NCT Number NCT03135730
Lead Sponsor Ilya Khaytin
Collaborators: ROHHAD Fight Inc.
Conditions
(from sponsor)
ROHHAD, Rapid-Onset Obesity With Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation
Related terms Hypoventilation, Primary Dysautonomias
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov